Support

Story preview

Eli Lilly CEO Bets On Weight-Loss Medicine Retatrutide As Next Growth Driver, Says Firm’s Future Has ‘Never Been Brighter’

Stocktwits

About this story

Published
Oct 13, 2026, 10:10 AM UTC

Topics in this story

#eli#lilly#ceo#bets#weight

Continue reading on the publisher site for the full article.

Read on publisher →Stocktwits

News Atlas is free and independent. If it’s useful to you, you can support it with a coffee. ☕ Buy me a coffee

At a glance

Coverage

Tone

Who else is covering this

Where in the world it’s covered

Coverage over time

Tone of the coverage

About the publisher

Related topics

Eli Lilly CEO Bets On Weight-Loss Medicine Retatrutide As Next Growth Driver, Says Firm’s Future Has ‘Never Been Brighter’ · News Atlas